Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.62 -0.88%   SPY: 165.93 -0.74%
Profile Portfolio Notes & Links Tracked By  


  Track this member and follow their portfolio moves with tickerspy™ alerts  

donbb


Portfolio List (2):
Pharm


Pharm  0.0%
Transports  -2.2%

  Performance       Ideas       Community  
 
Today:
Week:
1-month:
All-time:
0.0%
-6.5%
+17.2%
+83.9%
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
+0.7%
-6.4%
+11.0%
+57.0%
     
Similar Portfolios also own:
BIIB, GILD, CELG, AMGN, VRTX, BMRN, LIFE, ILMN, AFFY, SCC
 

     
Share this portfolio on Facebook
Share this portfolio on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Portfolio HistoryNEW    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Gain View as: Alerts Comments
 ALXN $100.57 -2.10 -2.0% 1,131,564 71% $20.0B - 23% -16% +30.6% new: Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in
edited 01/18/12
 REGN $262.42 +2.46 +0.9% 1,060,364 65% $25.4B - 145% -8% +232.5% new: Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company. Regeneron discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. As of December 31, 2010, the Company had one market
added 01/18/12
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss this portfolio with donbb
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Dupilumab, a New Drug, May Help Some Asthmatics
REGN  SNY  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 21, 04:12PM from (www.nytimes.com)
The number of asthma attacks or other outbreaks of symptoms decreased by 87 percent in those getting the drug, Dupilumab,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top New Biotech Ideas from PropThink
CELG  REGN  CBST  VPHM  ONXX  AVEO  MAKO  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com)
The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Deutsche Bank Firm on Biotech Stocks to Buy
AMGN  CELG  REGN  BIIB  VRTX  GILD  ALXN  ONXX  DB  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 08:10AM from (247wallst.com)
Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest in Vertex Rises, in Celgene Falls
BMY  PFE  JNJ  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 11, 10:45AM from (www.benzinga.com)
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Midcaps Double S&P 500 Return: Get the Right ETF
XOM  FRT  GE  KSU  AAPL  O  WRI  REGN  VRTX  MDY  BRE  VO  IJH  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 07, 09:00AM from (ycharts.com)
Granted, Regeneron Pharmaceutical (REGN) Kansas City Southern (KSU) and Vertex Pharmaceuticals (VRTX), the three largest  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data
CAT  SCHW  REGN  GILD  SPY  ARNA  SCOR  PKT  UUP  LNKD  KRFT  TLT  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 03, 04:28PM from (www.benzinga.com)
The U.S. stock market jumped on Friday to end the trading week. The catalyst for the move higher was a strong jobs report,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Regeneron First-Quarter Profit Tops Estimates on Eylea
REGN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 03, 10:11AM from (www.bloomberg.com)
Regeneron Pharmaceuticals Inc. (REGN), maker of the eye medicine Eylea, reported first-quarter profit that topped analysts’  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Regeneron Reports First Quarter 2013 Financial and Operating Results
REGN  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 03, 06:30AM

TARRYTOWN, N.Y., May 3, 2013 /PRNewswire/ -- Regeneron  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top Wall Street Analyst Upgrades: Allergan, Arch, Petrobras and More
AGN  REGN  SPN  PVTB  IVZ  CNH  ACI  STX  REGI  LOCK  PBR  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 02, 08:40AM from (247wallst.com)
Investors and traders are always looking to find fresh research ideas that will lead to higher income or more profits. 24/7  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Regeneron Pharmaceuticals: The Stock That Only Goes Up?
AGN  REGN  SNY  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 01, 04:42PM from (www.benzinga.com)
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) were trading at new all-time high levels on Wednesday afternoon on concerns  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Wrap for Wednesday, May 1: Stocks Fall as Employment Data Weakens in April
AMD  AGN  REGN  SPY  ULTI  XXIA  MWA  UUP  SWI  RATE  TLT  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 01, 04:16PM from (www.benzinga.com)
The U.S. stock market was hit hard on Wednesday as investors reacted to a report which showed slowing employment conditions for the month of April.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Sellers Move into Celgene, Regeneron
BMY  JNJ  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  NVS  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - April 26, 01:25PM from (www.benzinga.com)
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alexion Reports First Quarter 2013 Results
ALXN  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 25, 06:30AM from (www.businesswire.com)
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results and a development pipeline update for the  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alexion Broadens and Strengthens its Executive Leadership Team
ALXN  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 25, 06:15AM from (www.businesswire.com)
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that it is broadening and strengthening its executive leadership  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Regeneron Pharmaceuticals to Replace MetroPCS in S&P 500 Index
REGN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - April 24, 05:52PM from (www.bloomberg.com)
Regeneron Pharmaceuticals Inc. (REGN), maker of the Eylea eye medicine, will replace MetroPCS Communications Inc. in the  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013
ALXN  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 11, 10:00AM from (www.businesswire.com)
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Sellers Move Out of Amgen, Celgene, Pharmacyclics
JNJ  MRK  AMGN  CELG  TEVA  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - April 10, 01:30PM from (www.benzinga.com)
The short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of March.

 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
UBS Top Picks for Second Quarter for 25 Percent Gains
DAL  HAL  ROST  C  WFM  MNST  ALXN  ACI  TIBX  UBS  NCT  KRA  WCRX  CIE  BLOX  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - April 02, 08:15AM from (247wallst.com)
When we started off 2013, most of the Wall St. firms we follow put out their top stock picks for the year. We covered those  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Plant Making Alexion’s $400,000-a-Year Anemia Drug Dinged by FDA Over Contamination Issues
ALXN  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - March 28, 05:14PM from (ycharts.com)
One of the darlings of the biotech industry has suffered a blow following an FDA inspection of its Rhode Island facility.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences
PFE  JNJ  AMGN  CELG  TEVA  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  GSK  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - March 28, 08:18AM from (www.benzinga.com)
The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of March.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 13



Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.